Table 1.

Indicators (monthly %) of neoadjuvant and adjuvant treatment defined using health information systems: background rate for breast, colon-rectal, and lung in the Lazio Region.

	Breast	Colon-rectal	Lung
	monthly rats 2013-19	monthly rate 2013-19	monthly rats2013-19
Patients with chemotherapy in the 60 days pre admission	3.9%	1.7%	1.3%
Patients with radiotherapy in the 60 days pre admission	0.1%	3.0%	1.3%
Patients with chemotherapy in the 50 days post discharge*	18.7%	27.0%	19.3%
Patients with radiotherapy in the 60 days pre admission	12.8%	0.7%	2.3%
Patients with immunotherapy in the SO days post discharge	7.3%	0.2%	0.8%
Patients with hormone therapy in the 60 days post discharge	43.8%	-	-

*The following pre-and post- COVID-19 indicators will be analyzed for patients receiving chemotherapy:

 ■median time between first chemotherapy administration and discharge;

 ■pattern of drug use and formulations (oral, intravenous and subcutaneous);

 ■percentage of patients with first chemotherapy at the same hospital that performed surgery.